Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

Indian shares were flat to slightly higher on Tuesday, with metal, oil/gas and power stocks pacing the gainers. The benchmark ...

Oct. 11, 2023 — Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study identified the ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...

While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The HIMALAYA study showed that the combination of tremelimumab and durvalumab significantly improved overall survival in ...

Patients with limited-stage small cell lung cancer saw improvements in progression-free survival and overall survival with ...